Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences

REFERENCES

• Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59: 284–291.
   PubMed Web of Science ®Google Scholar
• Andrulis, E. D., E. Guzmán, P. Döring, J. Werner, and J. T. Lis. 2000. High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and transcription elongation. Genes Dev. 14: 2635–2649.
   PubMed Web of Science ®Google Scholar
• Artsimovitch, I., and R. Landick. 2001. Pausing by bacterial RNA polymerase is mediated by mechanistically distinct classes of signals. Proc. Natl. Acad. Sci. USA 97: 7090–7095.
   Google Scholar
• Awrey, D. E., R. G. Weilbaecher, S. A. Hemming, S. M. Orlicky, C. M. Kane, and A. M. Edwards. 1997. Transcription elongation through DNA arrest sites: a multistep process involving both RNA polymerase II subunit RPB9 and TFIIS. J. Biol. Chem. 272: 14747–14754.
   PubMed Web of Science ®Google Scholar
• Berkhout, B., R. H. Silverman, and K.-T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273–282.
   PubMed Web of Science ®Google Scholar
• Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17: 7056–7065.
   PubMed Web of Science ®Google Scholar
• Bradsher, J., F. Coin, and J.-M. Egly. 2000. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape. J. Biol. Chem. 275: 2532–2538.
   PubMed Web of Science ®Google Scholar
• Chen, D., Y. Fong, and Q. Zhou. 1999. Specific interaction of Tat with the human but not rodent pTEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96: 2728–2733.
   PubMed Web of Science ®Google Scholar
• Chen, D., and Q. Zhou. 1999. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol. Cell. Biol. 19: 2863–2871.
   PubMed Web of Science ®Google Scholar
• Christie, K. R., D. E. Awrey, A. M. Edwards, and C. M. Kane. 1994. Purified yeast RNA polymerase II reads through intrinsic blocks to elongation in response to the yeast TFIIS analogue, p37. J. Biol. Chem. 269: 936–943.
   PubMedGoogle Scholar
• Churcher, M. J., A. D. Lowe, M. J. Gait, and J. Karn. 1995. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. Proc. Natl. Acad. Sci. USA 92: 2408–2412.
   PubMedGoogle Scholar
• Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86: 6925–6929.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96: 1285–1290.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., and K. A. Jones. 1999. HIV-1 Tat: coping with negative elongation factors. Curr. Opin. Immunol. 11: 460–465.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol. Cell Biol. 20: 6958–6969.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., P. Wei, V. N. KewelRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12: 3512–3527.
   PubMed Web of Science ®Google Scholar
• Graeble, M. A., M. J. Churcher, A. D. Lowe, M. J. Gait, and J. Karn. 1993. Human immunodeficiency virus type 1 trans-activator protein Tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc. Natl. Acad. Sci. USA 90: 6184–6188.
   PubMedGoogle Scholar
• Greenblatt, J., J. R. Nodwell, and S. W. Mason. 1993. Transcriptional antitermination. Nature 364: 401–406.
   PubMed Web of Science ®Google Scholar
• Hartzog, G. A., T. Wada, H. Handa, and F. Winston. 1998. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12: 357–369.
   PubMed Web of Science ®Google Scholar
• Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69: 1612–1620.
   PubMed Web of Science ®Google Scholar
• Isel, C., and J. Karn. 1999. Direct evidence that HIV-1 Tat activates the Tat-associated kinase (TAK) during transcriptional elongation. J. Mol. Biol. 290: 929–941.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Y. T. Kwak, J. Guo, and R. B. Gaynor. 2000. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20: 2970–2983.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Y. T. Kwak, E. Nee, J. Guo, L. F. Garcia-Martinez, and R. B. Gaynor. 1999. Cyclin T domains involved in complex formation with Tat and TAR RNA are critical for Tat-activation. J. Mol. Biol. 288: 41–56.
   PubMedGoogle Scholar
• Kao, S.-Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product. Nature 330: 489–493.
   PubMed Web of Science ®Google Scholar
• Kaplan, C. D., J. R. Morris, C.-T. Wu, and F. Winston. 2000. Spt5 and Spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes Dev. 14: 2623–2634.
   PubMed Web of Science ®Google Scholar
• Karn, J. 1999. Tackling Tat. J. Mol. Biol. 293: 235–254.
   PubMed Web of Science ®Google Scholar
• Kato, H., H. Sumimoto, P. Pognonec, C.-H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6: 655–666.
   PubMed Web of Science ®Google Scholar
• Keen, N. J., M. J. Churcher, and J. Karn. 1997. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16: 5260–5272.
   PubMedGoogle Scholar
• Keen, N. J., M. J. Gait, and J. Karn. 1996. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93: 2505–2510.
   PubMedGoogle Scholar
• Kerppola, T. K., and C. M. Kane. 1990. Analysis of signals for transcription termination by purified RNA polymerase II. Biochemistry 29: 269–278.
   PubMedGoogle Scholar
• Kim, J. B., and P. A. Sharp. 2001. Positive transcription elongation factor b phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 276: 12317–12323.
   PubMed Web of Science ®Google Scholar
• Kulish, D., and K. Struhl. 2001. TFIIS enhances transcriptional elongation through an artificial arrest site in vivo. Mol. Cell. Biol. 21: 4162–4168.
   PubMedGoogle Scholar
• Kumar, K. P., S. Akoulitchev, and D. Reinberg. 1998. Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event. Proc. Natl. Acad. Sci. USA 95: 9767–9772.
   PubMedGoogle Scholar
• Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 Tat-activation. J. Mol. Biol. 288: 57–69.
   PubMedGoogle Scholar
• Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283–292.
   PubMed Web of Science ®Google Scholar
• Lin, R., D. Gewert, and J. Hiscott. 1999. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270: 3123–3131.
   Google Scholar
• Liu, Y., C. Suñé, and M. A. Garcia-Blanco. 1999. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex. Virology 255: 337–346.
   PubMedGoogle Scholar
• Mancebo, H. S. Y., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. p-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11: 2633–2644.
   PubMed Web of Science ®Google Scholar
• Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63: 791–802.
   PubMed Web of Science ®Google Scholar
• Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10: 4189–4196.
   PubMed Web of Science ®Google Scholar
• Palangat, M., and R. Landick. 2001. Roles of RNA:DNA hybrid stability, RNA structure, and active site conformation in pausing by human RNA polymerase II. J. Mol. Biol. 311: 265–282.
   PubMedGoogle Scholar
• Palangat, M., T. I. Meier, R. G. Keene, and R. Landick. 1998. Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure. Mol. Cell 1: 1033–1042.
   PubMed Web of Science ®Google Scholar
• Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384: 375–378.
   PubMed Web of Science ®Google Scholar
• Parada, C. A., J.-B. Yoon, and R. G. Roeder. 1995. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J. Biol. Chem. 270: 2274–2283.
   PubMed Web of Science ®Google Scholar
• Pasman, Z., and P. H. von Hippel. 2000. Regulation of Rho-dependent transcription termination by NusG is specific to the Escherichia coli elongation complex. Biochemistry 39: 5573–5585.
   PubMedGoogle Scholar
• Ping, Y.-H., and T. M. Rana. 1999. Tat-associated kinase (P-TEF-b): a component of transcription preinitiation and elongation complexes. J. Biol. Chem. 274: 7399–7404.
   PubMed Web of Science ®Google Scholar
• Ping, Y. H., and T. M. Rana. 2001. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates pTEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276: 12951–12958.
   PubMed Web of Science ®Google Scholar
• Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20: 2629–2634.
   PubMed Web of Science ®Google Scholar
• Renner, D. B., Y. Yamaguchi, T. Wada, H. Handa, and D. H. Price. 2001. A highly purified RNA polymerase II elongation control system. J. Biol. Chem. 276: 42601–42609.
   PubMed Web of Science ®Google Scholar
• Rittner, K., M. J. Churcher, M. J. Gait, and J. Karn. 1995. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 248: 562–580.
   PubMedGoogle Scholar
• Selby, M. J., E. S. Bain, P. Luciw, and B. M. Peterlin. 1989. Structure, sequence and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev. 3: 547–558.
   PubMed Web of Science ®Google Scholar
• Sodroski, J., R. Patarca, C. Rosen, F. Wong-Staal, and W. A. Haseltine. 1985. Location of the trans-acting region on the genome of human T-cell lymphotropic virus type III. Science 229: 74–77.
   PubMed Web of Science ®Google Scholar
• Suñé, C., and M. A. Garcia-Blanco. 1995. Transcriptional trans-activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J. Virol. 69: 3098–3107.
   PubMed Web of Science ®Google Scholar
• Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264: 245–253.
   PubMed Web of Science ®Google Scholar
• Tirode, F., D. Busso, F. Coin, and J.-M. Egly. 1999. Reconstitution of the transcription factor TFIIH: assignment of functions for the three subunits XPB, XPD, and cdk7. Mol. Cell 3: 87–95.
   PubMed Web of Science ®Google Scholar
• von Hippel, P. H. 1998. An integrated model of the transcription complex in elongation, termination and editing. Science 281: 660–665.
   PubMed Web of Science ®Google Scholar
• Wada, T., G. Orphanides, J. Hasegawa, D.-K. Kim, D. Shima, Y. Yamaguchi, A. Fukada, K. Hisatake, O. Sangtaek, D. Reinberg, and H. Handa. 2000. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between p-TEFb and TFIIH. Mol. Cell 5: 1067–1072.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagai, Y. Yamaguchi, D. Watanabe, and H. Handa. 1998. Evidence that pTEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17: 7395–7403.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagi, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yano, G. A. Hartzog, F. Winston, S. Buratowski, and H. Handa. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12: 343–356.
   PubMed Web of Science ®Google Scholar
• Wei, P., M. E. Garber, S.-M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel cdk9-associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop specific binding to TAR RNA. Cell 92: 451–462.
   PubMed Web of Science ®Google Scholar
• Wu-Baer, F., W. S. Lane, and R. B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277: 179–197.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, J. Hasegawa, and H. Handa. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41–51.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., T. Wada, D. Watanabe, T. Takagi, J. Hasegawa, and H. Handa. 1999. Structure and function of the human transcription elongation factor DSIF. J. Biol. Chem. 274: 8085–8092.
   PubMed Web of Science ®Google Scholar
• Zawel, L., P. Kumar, and D. Reinberg. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev. 9: 1479–1490.
   PubMedGoogle Scholar
• Zhou, M., M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20: 5077–5086.
   PubMed Web of Science ®Google Scholar
• Zhou, Q., D. Chen, E. Pierstorff, and K. Luo. 1998. Transcription elongation factor p-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17: 3681–3691.
   PubMed Web of Science ®Google Scholar
• Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14: 321–328.
   PubMedGoogle Scholar
• Zhou, Q., and P. A. Sharp. 1996. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274: 605–610.
   PubMedGoogle Scholar
• Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor p-TEFb is required for HIV-1 Tat trans-activation in vitro. Genes Dev. 11: 2622–2632.
   PubMed Web of Science ®Google Scholar